UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029554
Receipt number R000028717
Scientific Title Study on Clinical Effects of Toothpaste Containing Propolis in Periodontitis Patients
Date of disclosure of the study information 2017/10/14
Last modified on 2021/10/19 14:09:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on Clinical Effects of Toothpaste Containing Propolis in Periodontitis Patients

Acronym

Effects of Toothpaste Containing Propolis in Periodontitis Patients

Scientific Title

Study on Clinical Effects of Toothpaste Containing Propolis in Periodontitis Patients

Scientific Title:Acronym

Effects of Toothpaste Containing Propolis in Periodontitis Patients

Region

Japan


Condition

Condition

Periodontitis

Classification by specialty

Dental medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This clinical study aimed to evaluate the clinical effects of the toothpaste containing propolis by comparison to the tooth paste not counting propolis in randomized controlled trial.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Amounts of bacteria in sub-gingival dental plaque after 4 weeks
(Total bacteria and Porphyromonas gingivivalis)

Key secondary outcomes

Nine points after 4 weeks
1) Probing pocket depth
2) Bleeding on probing
3) Activity of neutrophil elastase and total protein amounts in saliva
4) Ammonia in saliva
5) Cariogenic activity of saliva: amounts of cariogenic bacteria, acidity, buffer capacity
6) Microflora of sub-gingival dental plaque analyzed by next generation sequencer (2 subjects/group)
7) Questionnaire for impression of use of this toothpaste and its effective
8) Record of implementation
9) Questionnaire for the condition of pre-existing disease


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Tooth brushing with given toothbrush and toothpaste containing 5 mg/g propolis twice a day for 4 weeks

Interventions/Control_2

Tooth brushing with given toothbrush and toothpaste not containing propolis twice a day for 4 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Periodontitis patients in supportive periodontal therapy (SPT) phase (consulting period: more than 2 months interval) at Department of Periodontics and Endodontics of Okayama University Hospital
2) Good oral hygiene; good compliance during study period, judged by research dentist
3) Age is not less than 20 years old when obtaining informed consent.
4) Current number of teeth is not less than 20.
5) Patients with 3 or more teeth with 4- to 6-mm periodontal pocket
6) Patients with informed consent by document agree

Key exclusion criteria

1) Allergic for this toothpaste
2) Pregnancy or lactating period women
3) Unstable physical condition
4) Use of antibiotics / anti-inflammatory agents within 3 months
5) Acute symptom of periodontitis within 3 months
6) Smoker
7) Unifit patients judged by research dentists for compliance

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shogo Takashiba

Organization

Okayama University

Division name

Department of Pathophysiology - Periodontal Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama 700-8525, Japan

TEL

086-235-6675

Email

stakashi@okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shogo Takashiba

Organization

Okayama University

Division name

Department of Pathophysiology - Periodontal Science, Okayama University Graduate School of Medicine,

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama 700-8525, Japan

TEL

086-235-6675

Homepage URL


Email

stakashi@okayama-u.ac.jp


Sponsor or person

Institute

Okayama University

Institute

Department

Personal name



Funding Source

Organization

API Co., Ltd.
Business Strategy Section

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山大学病院(岡山市)


Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 14 Day


Related information

URL releasing protocol

None

Publication of results

Unpublished


Result

URL related to results and publications

None

Number of participants that the trial has enrolled

29

Results

Primary endpoints
Total bacterial count: There was no significant difference between the control and propolis groups before and after the test.
There was no significant difference in the number of Pg bacteria between the control and propolis groups before and after the test.

Results date posted

2021 Year 10 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Selection criteria: 1.
1. Selection criteria: Patients who meet the following conditions are eligible.
(1) Patients with periodontitis who have completed treatment for periodontitis at the Department of Periodontology, Okayama University Hospital, and whose condition is stable, and who continue to visit the hospital regularly for SPT (at intervals of 2 months or more).
(2) Patients whose oral hygiene is good and who are judged by the research physician to be able to clean their mouths according to the dentist's instructions during the study period.
(3) Patients who were 20 years of age or older at the time consent was obtained.
(4) Patients who currently have 20 or more teeth.
(5) Patients who still have periodontal pockets of 4-6 mm on at least 3 teeth.
(6) Patients who have obtained written consent from the patient himself/herself after receiving sufficient explanation for participation in this study.
2. Exclusion criteria
2. Exclusion criteria: Patients who violate any of the following criteria will not be included in this study.
(1) Patients who are allergic to toothpaste (if allergic symptoms occur)
(2) Pregnant or lactating women
(3) Patients whose general condition is unstable (those whose physical condition fluctuates greatly)
(4) Patients who have received topical or systemic antibiotics or anti-inflammatory drugs within the past 3 months
(5) Patients with acute symptoms of periodontitis within the past 3 months
(6) Smokers
(7) Others who are judged by the attending physician to be ineligible.

Participant flow

A randomized, double-blind study of the clinical effects of propolis-containing toothpaste on periodontitis compared with placebo toothpaste without propolis in patients in the SPT stage.

Adverse events

None

Outcome measures

Primary endpoint
Amount of bacteria in the subgingival plaque after 4 weeks (quantitative PCR method)
Subgingival plaque was collected by paper point from 3 teeth with 4-6 mm periodontal pockets, and DNA was extracted. The total number of bacteria and the number of Porphyromonas gingivalis (Pg) will be measured by real-time PCR using the extracted DNA sample as a template.
Secondary endpoint
The following 9 items will be measured after 4 weeks
(1) Periodontal pocket depth
The depth of periodontal pockets at three sites where subgingival plaque was collected will be measured by the method used in regular practice.
(2) BOP score
To measure the depth of periodontal pockets at three sites from which subgingival plaque was collected using the usual method, and to check for bleeding.
(3) Leukocyte esterase activity and total protein level in saliva
Measurement by test paper using Lion's test kit (Salivary Multitest: SMT; http://lionpro.lionshop.jp/).
(4) Ammonia in saliva
Ammonia, the cause of bad breath, is detected by bromocresol green coloration using SMT as well.
(5) Amount, acidity, and buffering capacity of caries-producing bacteria in saliva
Similarly, SMT is used to detect the ability of Gram-positive bacteria to reduce resazurin, which has been shown to be related to the number of caries-producing bacteria. In addition, the amount of hydrogen ion is detected from the color change of pH indicator, and the acidity related to the demineralization of tooth enamel is examined. In addition, the neutralizing power of saliva against acid (buffering capacity) is examined.
(6) Bacterial flora in subgingival plaque (NGS method)
DNA will be extracted from subgingival plaque, and metagenomic analysis of the oral bacterial flora will be performed using a next-generation sequencer (NGS). Four patients, two in each group, will be measured, and the measurements will be performed on the patients corresponding to the pre-determined toothpaste numbers.
(7) Questionnaire on the feeling of use and effect of toothpaste
(8) Subjects' diary (brushing status)
(9) Changes in underlying diseases (questionnaire)

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 01 Month 29 Day

Date of IRB

2017 Year 01 Month 17 Day

Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date

2017 Year 08 Month 31 Day

Date of closure to data entry

2017 Year 10 Month 31 Day

Date trial data considered complete

2018 Year 03 Month 31 Day

Date analysis concluded

2018 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 10 Month 14 Day

Last modified on

2021 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028717


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name